Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 5;385(6):562-566.
doi: 10.1056/NEJMsb2104756.

SARS-CoV-2 Variants in Patients with Immunosuppression

Lawrence Corey  1 , Chris Beyrer  1 , Myron S Cohen  1 , Nelson L Michael  1 , Trevor Bedford  1 , Morgane Rolland  1
Affiliations

SARS-CoV-2 Variants in Patients with Immunosuppression

Lawrence Corey et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Spike Protein Structure and Phylogenetic Tree of SARS-CoV-2 Viruses.
Panel A shows the spike protein structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (entry 6ZGE in the Worldwide Protein Data Bank [PDB]). Domains are colored according to their role in viral entry and antibody recognition; the terminal domain that is missing in 6ZGE is shaded in gray. As shown in the graphic above the chart, the spike protein consists of two subunits, with subunit 1 (S1) (the portions in yellow, purple, blue, green, and pink) containing the receptor-binding domain (RBD), the N-terminal domain (NTD), and several other subdomains and subunit 2 (S2) (the portion in gray) mediating fusion of the virus-cell membrane. Also shown are the spike mutations that are representative of circulating variants of concern (B.1.1.7, B.1.351, P.1, and B.1.617.2) or variants of interest (B.1.427/429, B.1.525, and B.1.526), as well as patterns of mutations identified over the course of persistent infections in immunocompromised patients, as described in case reports. Representative sequences from the case reports are listed according to the first author’s name (,,,,). Mutations in the NTD super- site are located nearby on the protein structure. Mutations are also recurring in the receptor-binding motif (RBM) and around the furin cleavage site. The symbols at the top of the columns indicate the N-linked glycosylation sites. CD denotes connector domain, CH center helix, CT cytoplasmic tail, HR1 heptad repeat 1, HR2 heptad repeat 2, SD1 subdomain 1, SD2 subdomain 2, S2′FP S2 fusion peptide, and TM transmembrane. Panel B shows the phylogenetic tree of 1510 SARS-CoV-2 viruses detected in patients in the United Kingdom between January 2020 and February 2021. The phylogeny is embedded as a root-to-tip plot, in which the x axis represents the date of sample collection and the y axis represents the number of genomewide mutations that have occurred since the phylogeny root. The phylogeny is colored according to the clade, as listed in the Nextstrain database (an online site for the sharing of sequencing and genomic data about SARS-CoV-2). Clade 20I/501Y.V1 in this database corresponds to lineage B.1.1.7 in the Phylogenetic Assignment of Named Global Outbreak Lineages (PANGO) and is colored in orange and annotated in the figure. The branch leading to lineage B.1.1.7 is annotated with selected mutations that are present along this single branch. Lineage B.1.1.7 has a higher number of mutations than most other circulating viruses and has rapidly displaced existing genetic diversity in the United Kingdom. The phylogeny is constructed from sequence data shared to GISAID (a database of genomic information regarding influenza viruses and coronaviruses) by means of methods implemented by Nextstrain.
Figure 1.
Figure 1.. Spike Protein Structure and Phylogenetic Tree of SARS-CoV-2 Viruses.
Panel A shows the spike protein structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (entry 6ZGE in the Worldwide Protein Data Bank [PDB]). Domains are colored according to their role in viral entry and antibody recognition; the terminal domain that is missing in 6ZGE is shaded in gray. As shown in the graphic above the chart, the spike protein consists of two subunits, with subunit 1 (S1) (the portions in yellow, purple, blue, green, and pink) containing the receptor-binding domain (RBD), the N-terminal domain (NTD), and several other subdomains and subunit 2 (S2) (the portion in gray) mediating fusion of the virus-cell membrane. Also shown are the spike mutations that are representative of circulating variants of concern (B.1.1.7, B.1.351, P.1, and B.1.617.2) or variants of interest (B.1.427/429, B.1.525, and B.1.526), as well as patterns of mutations identified over the course of persistent infections in immunocompromised patients, as described in case reports. Representative sequences from the case reports are listed according to the first author’s name (,,,,). Mutations in the NTD super- site are located nearby on the protein structure. Mutations are also recurring in the receptor-binding motif (RBM) and around the furin cleavage site. The symbols at the top of the columns indicate the N-linked glycosylation sites. CD denotes connector domain, CH center helix, CT cytoplasmic tail, HR1 heptad repeat 1, HR2 heptad repeat 2, SD1 subdomain 1, SD2 subdomain 2, S2′FP S2 fusion peptide, and TM transmembrane. Panel B shows the phylogenetic tree of 1510 SARS-CoV-2 viruses detected in patients in the United Kingdom between January 2020 and February 2021. The phylogeny is embedded as a root-to-tip plot, in which the x axis represents the date of sample collection and the y axis represents the number of genomewide mutations that have occurred since the phylogeny root. The phylogeny is colored according to the clade, as listed in the Nextstrain database (an online site for the sharing of sequencing and genomic data about SARS-CoV-2). Clade 20I/501Y.V1 in this database corresponds to lineage B.1.1.7 in the Phylogenetic Assignment of Named Global Outbreak Lineages (PANGO) and is colored in orange and annotated in the figure. The branch leading to lineage B.1.1.7 is annotated with selected mutations that are present along this single branch. Lineage B.1.1.7 has a higher number of mutations than most other circulating viruses and has rapidly displaced existing genetic diversity in the United Kingdom. The phylogeny is constructed from sequence data shared to GISAID (a database of genomic information regarding influenza viruses and coronaviruses) by means of methods implemented by Nextstrain.
See this image and copyright information in PMC

References

    1. Avanzato VA, Matson MJ, Seifert SN, et al. Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 2020;183(7):1901.e9–1912.e9. - PMC - PubMed
    1. Choi B, Choudhary MC, Regan J, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med 2020;383:2291–3. - PMC - PubMed
    1. Truong TT, Ryutov A, Pandey U, et al. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. March 2, 2021. (https://www.medrxiv.org/content/10.1101/2021.02.27.21252099v1). preprint. - DOI - PMC - PubMed
    1. Kemp SA, Collier DA, Datir RP, et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature 2021;592:277–82. - PMC - PubMed
    1. Abdool Karim SS, de Oliveira T. New SARS-CoV-2 variants — clinical, public health, and vaccine implications. N Engl J Med 2021; 384:1866–8. - PMC - PubMed